Citation Impact
Citing Papers
Human Hypertension Caused by Mutations in WNK Kinases
2001 StandoutScience
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Cord Blood Vitamin D Deficiency Is Associated With Respiratory Syncytial Virus Bronchiolitis
2011
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Effects of Epidural Anesthesia and Analgesia on Coagulation and Outcome After Major Vascular Surgery
1991
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
2007
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Bone Disease after Renal Transplantation
2006
High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death
2008
Bone Mineral Density in Patients Beginning Hemodialysis Treatment
2002
Variation in Serum and Plasma PTH Levels in Second-Generation Assays in Hemodialysis Patients: A Cross-sectional Study
2008
Osteoporosis
2019 Standout
The Pharmacogenetics of Immunosuppression for Organ Transplantation
2003
Association of Changes in Bone Remodeling and Coronary Calcification in Hemodialysis Patients: A Prospective Study
2008
Oral Phosphate Binders in Patients with Kidney Failure
2010
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
2013 StandoutNobel
Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study
2005
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
2006
Effects of DeflazacortVersusPrednisone on Bone Mass, Body Composition, and Lipid Profile: A Randomized, Double Blind Study in Kidney Transplant Patients1
1998
Therapeutic uses of vitamin D analogues
2001
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
Vitamin D Deficiency
2007 Standout
Vitamin D Deficiency and Associated Factors in Hemodialysis Patients
2008
Clinical Pharmacokinetics in Organ Transplant Patients
1989
Flavonoid-induced reduction of ENaC expression in the kidney of Dahl salt-sensitive hypertensive rat
2004
A Common Variant of the PAX2 Gene Is Associated with Reduced Newborn Kidney Size
2007
Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients
2003
Essential Role for Retinoic Acid in the Promotion of CD4+ T Cell Effector Responses via Retinoic Acid Receptor Alpha
2011
Malignancy in Renal Transplantation
2004
Chronic kidney disease
2011 Standout
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
1998 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis
2008
Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
2008
Trends in Mineral Metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004
2008
Glucocorticoids and invasive fungal infections
2003
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
The Effects of Sevelamer and Calcium Acetate on Proxies of Atherosclerotic and Arteriosclerotic Vascular Disease in Hemodialysis Patients
2003
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Renal Osteodystrophy, Phosphate Homeostasis, and Vascular Calcification
2007
Bone mineral density and bone histomorphometry in children on long-term dialysis
2007
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study
2008
Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients
2007
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Association of Bone Activity, Calcium Load, Aortic Stiffness, and Calcifications in ESRD
2008
Bone mineral density changes within six months of renal transplantation
2003
Parathyroid Hormone Has a Prosclerotic Effect on Vascular Smooth Muscle Cells
2003
Remodelling the extracellular matrix in development and disease
2014 Standout
Serum cytokines in juvenile rheumatoid arthritis: correlation with conventional inflammation parameters and clinical subtypes
1995
Pitfalls of Measuring Total Blood Calcium in Patients with CKD
2008
Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease
2008
Practical considerations in PTH testing
2005
Type 1 diabetes
2013 Standout
Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients
2003
Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily
2001
Calcium kinetics and the long-term effects of lowering dialysate calcium concentration
1993
Meta-Analysis of Biochemical and Patient-Level Effects of Calcimimetic Therapy
2006
Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D
2006
Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD
2006
25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients
2008
Pharmacological and clinical properties of calcimimetics: Calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism
2005
Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis
2007
1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line
2001
The impact of the assay for measuring albumin on corrected ('adjusted') calcium concentrations
2009
The interleukin‐1 genotype as a severity factor in adult periodontal disease
1997 Standout
K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients
2008
Periodontal diseases
2005 Standout
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism
2010
Predictors of bone mineral density in patients on hemodialysis
2004
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism
2005
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
2008
Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease: An Overview
2005
Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial
2002 Standout
Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients
2007
FGF-23 and secondary hyperparathyroidism in chronic kidney disease
2013
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Effects of Sevelamer Hydrochloride and Calcium Carbonate on Renal Osteodystrophy in Hemodialysis Patients
2008
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
1988 Standout
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
2005 Standout
Osteoporosis in the elderly with chronic kidney disease
2006
Chronic Kidney Disease
2016 Standout
Infection in Organ-Transplant Recipients
1998 Standout
A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response
2013
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
2008 Standout
Kidney Disease: Improving Global Outcomes
2009
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
2011 Standout
Post-renal transplantation hypophosphatemia: a review and novel insights
2006
Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation
2010
PTH/PTHrP Receptor in Early Development and Indian Hedgehog—Regulated Bone Growth
1996 StandoutScience
The kinase Grk2 regulates Nedd4/Nedd4-2-dependent control of epithelial Na + channels
2004 StandoutNobel
Survival after Parathyroidectomy in Patients with End‐stage Renal Disease and Severe Hyperparathyroidism
2007
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
2011
Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease
2007
3 Regulation of vasopressin secretion
1989
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
2014
Toll-like Receptor 4 Modulation as a Strategy to Treat Sepsis
2010
Inherited Variation in Vitamin D Genes Is Associated With Predisposition to Autoimmune Disease Type 1 Diabetes
2011
Normal Modes of Prion Proteins: From Native to Infectious Particle
2011 StandoutNobel
Plasmodium products persist in the bone marrow and promote chronic bone loss
2017
Measures of Renal Function, BMD, Bone Loss, and Osteoporotic Fracture in Older Adults: The Rancho Bernardo Study
2006
Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease
2008
The Tumor Lysis Syndrome
2011 Standout
Strength of TCR–Peptide/MHC Interactions and In Vivo T Cell Responses
2011 StandoutNobel
Sense-and-Respond Payload Delivery Using a Novel Antigen-Inducible Promoter Improves Suboptimal CAR-T Activation
2022
Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection
2011 StandoutNobel
Characterization of a novel parathyroid hormone (PTH) receptor with specificity for the carboxyl-terminal region of PTH-(1-84)
1995
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Zanvil Alexander Cohn 1926-1993.
1994 StandoutNobel
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
2017
Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates
2012
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Bone Mass and Dynamic Parathyroid Function According to Bone Histology in Nondialyzed Uremic Patients after Long-Term Protein and Phosphorus Restriction
1999
Membrane flow during pinocytosis. A stereologic analysis.
1976 StandoutNobel
IN VITRO SYNTHESIS AND SECRETION OF LYSOZYME BY MONONUCLEAR PHAGOCYTES
1974
Vitamin D compounds for people with chronic kidney disease requiring dialysis
2009
Functional and morphological renal manifestations in diabetes mellitus
1981
B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice
2021 StandoutNobel
Growth hormone for children with chronic kidney disease
2012
Carrier-Based Ion-Selective Electrodes and Bulk Optodes. 2. Ionophores for Potentiometric and Optical Sensors
1998 Standout
Theory and applications of ion-selective electrodes part II
1977
Effect of Phosphate on Parathyroid Hormone Secretion In Vivo
1999
Secretory products of macrophages.
1987 Standout
Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.
1992
Specialized Membrane Domains for Water Transport in Glial Cells: High-Resolution Immunogold Cytochemistry of Aquaporin-4 in Rat Brain
1997 StandoutNobel
Bone metabolism and disease in chronic kidney disease
2003
Effects of Metoclopramide and Bromocriptine on the Renin-Angiotensin-Aldosterone System in Man
1979
Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism
2003
Dopamine Receptors: From Structure to Function
1998 Standout
T-cell receptor ligation induces distinct signaling pathways in naïve vs. antigen-experienced T cells
2011
Physiology of Microglia
2011 Standout
Extracellular Calcium Sensing and Extracellular Calcium Signaling
2001
Familial Hyperpotassemia and Hypertension Accompanied by Normal Plasma Aldosterone Levels
1978
Works of Klaus Ølgaard being referenced
Evaluation of a new automatic calcium ion analyzer.
1977
CONSISTENT ABSORPTION OF CYCLOSPORINE FROM A MICROEMULSION FORMULATION ASSESSED IN STABLE RENAL TRANSPLANT RECIPIENTS OVER A ONE-YEAR STUDY PERIOD
1995
Abnormal Bone and Mineral Metabolism in Kidney Transplant Patients – A Review
2007
Recombinant Human Growth Hormone Treatment, Using Two Dose Regimens in Children with Chronic Renal Failure - A Report on Linear Growth and Adverse Effects
2002
Effect of 1,25-dihydroxy-vitamin D3 in experimental sepsis
2007
Effect of Intravenous 1-Alpha-Hydroxyvitamin D<sub>3</sub> on Secondary Hyperparathyroidism in Chronic Uremic Patients on Maintenance Hemodialysis
1989
Kidney growth in 717 healthy children aged 0?18�months: a longitudinal cohort study
2004
Five to 10 years follow-up after total parathyroidectomy and autotransplantation of parathyroid tissue: Evaluation of parathyroid function by use of ischaemic blockade manoeuvre
1996
The Effect of 1,25‐Vitamin D3 on Calbindin‐D and Calcium‐Metabolic Variables in the Rat
1998
Parathyroid Hormone 7-84 Induces Hypocalcemia and Inhibits the Parathyroid Hormone 1-84 Secretory Response to Hypocalcemia in Rats with Intact Parathyroid Glands
2006
Microalbuminuria as an early indicator of osteopenia in male insulin-dependent diabetic patients
1997
Effects of excess PTH on nonclassical target organs
1997
Influence of Calcium on the Metabolism of Intact Parathyroid Hormone by Isolated Perfused Rat Kidney and Liver*
1990
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Inhibition of PTH Secretion by Interleukin-1β in Bovine Parathyroid Glandsin VitroIs Associated with an Up-Regulation of the Calcium-Sensing Receptor mRNA
1997
Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: A double-blind study on the high-dose, long-term effects of prednisone versus deflazacort
1992
Role of calcitonin in the rapid minute‐to‐minute regulation of plasma Ca2+ homeostasis in the rat
2002
A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice
2008
Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure
1999
Randomized crossover study comparing the phosphate-binding efficacy of calcium ketoglutarate versus calcium carbonate in patients on chronic hemodialysis
1998
Chronic Renal Failure Accelerates Atherogenesis in Apolipoprotein E–Deficient Mice
2003
Increased parathyroid expression of klotho in uremic rats
2010
The in vivo effect of a new, in vitro, extremely potent vitamin D3 analog KH1060 on the suppression of renal allograft rejection in the rat
1994
Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure
2004
Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy
2004
Persistent Downregulation of Calcium-Sensing Receptor mRNA in Rat Parathyroids when Severe Secondary Hyperparathyroidism Is Reversed by an Isogenic Kidney Transplantation
2002
Vitamin D controls T cell antigen receptor signaling and activation of human T cells
2010
Increased Expression of Adhesion Molecules in Uremic Atherosclerosis in Apolipoprotein-E–Deficient Mice
2004
Relationship between plasma osmolality and plasma vasopressin in human subjects
1980
Effect of chronic uremia on the transcriptional profile of the calcified aorta analyzed by RNA sequencing
2016
Glucocorticoid-Induced Osteoporosis in the Lumbar Spine, Forearm, and Mandible of Nephrotic Patients: A Double-Blind Study on the High-Dose, Long-Term Effects of Prednisone Versus Deflazacort
1993
Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient Mice
2007
European Best Practice Guidelines for Renal Transplantation (Part 2).
2002
A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells
1996
1‐Alpha‐hydroxycholecalciferol Treatment of Adults with Chronic Renal Failure
1976
The immunosuppressive potency in vitro of physiological and synthetic steroids on lymphocyte cultures
1987
Posttransplant bone disease
2003
Degree and Course of Skeletal Demineralization in Patients with Chronic Renal Insufficiency
1978
The influence of potassium and ACTH on plasma-aldosterone regulation in anephric patients.
1976
Lysozyme turnover in man
1972
Pathogenesis of Hypophosphatemia in Kidney Necrograft Recipients: A Controlled Trial
1980
Inhibition of prednisolone metabolism by cyclosporine in kidney-transplanted patients.
1985
Aldosterone metabolism in the isolated perfused liver of R and S hypertension-prone Dahl rats
1992
Uremia-Specific Effects in the Arterial Media During Development of Uremic Atherosclerosis in Apolipoprotein E–Deficient Mice
2005
A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells
1996
Prevention of Uremic Bone Disease Using Calcimimetic Compounds
2001
Isolated perfused rat kidney and liver combined
1987
Epidural Analgesia Inhibits the Renin and Aldosterone Response to Surgery
1979
LACK OF EFFECT OF PROLACTIN INHIBITION BY ALPHA-BROMOERGOCRIPTINE (CB 154) ON PLASMA ALDOSTERONE IN ANEPHRIC AND NON-NEPHRECTOMIZED PATIENTS ON REGULAR HAEMODIALYSIS
1977
The effect of cyclosporine A on the hepatic clearance rate of prednisone in isolated perfused livers of normal and uremic rats.
1988